A large observational study found the increased risk associated with dual antiplatelet therapy cessation after percutaneous coronary intervention (PCI) is tied to patient non-adherence, as opposed to physician-recommended discontinuation. Results of the PARIS registry were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.


TeraRecon previewed a flexible new pay-as-you-go billing option for it cloud and laptop users of its iNtuition advanced visualization tools. The software supports physicians involved in TAVI/TAVR, EVAR and TEVAR, at the 39th Annual Veith Symposium in New York Nov. 14 – 16, 2012.

St. Jude Medical Inc. announced that the company’s EnligHTN renal denervation system provides a safe, effective and sustained reduction in office and ambulatory blood pressure measurements at six months. The new data was released in the Clinical Science and Special Reports Session during the annual American Heart Association (AHA) meeting.

TriVascular Inc. announced premarket approval (PMA) of the Ovation Abdominal Stent Graft System by the U.S. Food and Drug Administration (FDA) for the treatment of abdominal aortic aneurysms (AAA). Delivered through a 14 French (4.7 mm) outer diameter catheter, Ovation is the lowest profile commercially available system for EVAR.

November 26, 2012 — At the 98th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Siemens Healthcare is displaying for the first time its new X-ray tube and detector technology for the Artis Q and Artis Q.zen angiography systems, designed to improve minimally invasive therapy of diseases such as coronary artery disease, stroke and cancer.

November 26, 2012 — At the 98th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Siemens Healthcare is introducing the Acuson Freestyle ultrasound system, a system featuring wireless transducers that eliminate the impediment of cables in ultrasound imaging.

Subscribe Now